{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:03:59Z","timestamp":1791745439641,"version":"4.3.4"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10495-026-02279-1","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T06:26:26Z","timestamp":1770013586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ferroptosis-centered strategies: redefining therapeutic resistance & adaptation in modern oncology"],"prefix":"10.1007","volume":"31","author":[{"given":"Dineshkumar","family":"Madappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu Bommenahalli","family":"Krishnegowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8046-2990","authenticated-orcid":false,"given":"Prasiddhi","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan Beejadi","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohith","family":"Hadapada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwanth","family":"Sriramareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Goudanavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2279_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25:424\u2013442. https:\/\/doi.org\/10.1038\/s41580-024-00703-5","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2279_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-024-01545-6","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu J, Wan A et al (2024) Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and Disulfidptosis. J Hematol Oncol 17:22. https:\/\/doi.org\/10.1186\/s13045-024-01545-6","journal-title":"J Hematol Oncol"},{"key":"2279_CR3","doi-asserted-by":"publisher","first-page":"112819","DOI":"10.1016\/j.intimp.2024.112819","volume":"140","author":"W Dong","year":"2024","unstructured":"Dong W, Xu H, Wei W et al (2024) Advances in the study of ferroptosis and its relationship to autoimmune diseases. Int Immunopharmacol 140:112819. https:\/\/doi.org\/10.1016\/j.intimp.2024.112819","journal-title":"Int Immunopharmacol"},{"key":"2279_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/ars.2024.0608","volume":"41","author":"TA Muluh","year":"2024","unstructured":"Muluh TA, Fu Q, Ai X et al (2024) Targeting ferroptosis as an advance strategy in cancer therapy. Antioxid Redox Signal 41:616\u2013636. https:\/\/doi.org\/10.1089\/ars.2024.0608","journal-title":"Antioxid Redox Signal"},{"key":"2279_CR5","doi-asserted-by":"publisher","first-page":"1196287","DOI":"10.3389\/fphar.2023.1196287","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Hu J, Chen L et al (2023) Ferroptosis as an emerging therapeutic target in liver diseases. Front Pharmacol 14:1196287. https:\/\/doi.org\/10.3389\/fphar.2023.1196287","journal-title":"Front Pharmacol"},{"key":"2279_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/biom14070876","volume":"14","author":"LA Mielke Cabello","year":"2024","unstructured":"Mielke Cabello LA, Meresman G, Darici D et al (2024) Assessment of the ferroptosis regulators: glutathione peroxidase 4, Acyl-Coenzyme A synthetase Long-Chain family member 4, and transferrin receptor 1 in Patient-Derived endometriosis tissue. Biomolecules 14:876. https:\/\/doi.org\/10.3390\/biom14070876","journal-title":"Biomolecules"},{"key":"2279_CR7","doi-asserted-by":"publisher","first-page":"1567994","DOI":"10.3389\/fimmu.2025.1567994","volume":"16","author":"M Yao","year":"2025","unstructured":"Yao M, Liu Z, Zhao W et al (2025) Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities. Front Immunol 16:1567994. https:\/\/doi.org\/10.3389\/fimmu.2025.1567994","journal-title":"Front Immunol"},{"key":"2279_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13008-024-00127-9","volume":"19","author":"F Vana","year":"2024","unstructured":"Vana F, Szabo Z, Masarik M, Kratochvilova M (2024) The interplay of transition metals in ferroptosis and pyroptosis. Cell Div 19:24. https:\/\/doi.org\/10.1186\/s13008-024-00127-9","journal-title":"Cell Div"},{"key":"2279_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D et al (2024) Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Sig Transduct Target Ther 9:55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5","journal-title":"Sig Transduct Target Ther"},{"key":"2279_CR10","doi-asserted-by":"publisher","first-page":"217392","DOI":"10.1016\/j.canlet.2024.217392","volume":"611","author":"A Carlos","year":"2025","unstructured":"Carlos A, Mendes M, Cruz MT et al (2025) Ferroptosis driven by nanoparticles for tackling glioblastoma. Cancer Lett 611:217392. https:\/\/doi.org\/10.1016\/j.canlet.2024.217392","journal-title":"Cancer Lett"},{"key":"2279_CR11","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","volume":"38","author":"J Zugazagoitia","year":"2016","unstructured":"Zugazagoitia J, Guedes C, Ponce S et al (2016) Current challenges in cancer treatment. Clin Ther 38:1551\u20131566. https:\/\/doi.org\/10.1016\/j.clinthera.2016.03.026","journal-title":"Clin Ther"},{"key":"2279_CR12","first-page":"15","volume-title":"Progress in tumor research","author":"G Curigliano","year":"2014","unstructured":"Curigliano G, Criscitiello C (2014) Successes and limitations of targeted cancer therapy in breast cancer. In: Peters S, Stahel RA (eds) Progress in tumor research. S. Karger, AG, pp 15\u201335"},{"key":"2279_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2279_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1","journal-title":"Cell Res"},{"key":"2279_CR15","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.1039\/D5NR03627E","volume":"17","author":"Y Tang","year":"2025","unstructured":"Tang Y, Zhou Q, Fan Y et al (2025) Nanomaterial-mediated ferroptosis as a promising strategy for cancer therapy. Nanoscale 17:27066\u201327084. https:\/\/doi.org\/10.1039\/D5NR03627E","journal-title":"Nanoscale"},{"key":"2279_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2147\/NSA.S550828","volume":"18","author":"M Szwed","year":"2025","unstructured":"Szwed M, Poczta-Krawczyk A, Bukowski K, Marczak A (2025) Nanoparticle-Mediated ferroptosis for cancer therapy: mechanisms and therapeutic strategies. NSA Volume 18:445\u2013470. https:\/\/doi.org\/10.2147\/NSA.S550828","journal-title":"NSA Volume"},{"key":"2279_CR17","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1039\/D5NH00170F","volume":"10","author":"Q Chen","year":"2025","unstructured":"Chen Q, Zhu J, Jiang J, Huang Z (2025) Overview and SWOT analysis of nano-ferroptosis therapy for cancers. Nanoscale Horiz 10:1838\u20131862. https:\/\/doi.org\/10.1039\/D5NH00170F","journal-title":"Nanoscale Horiz"},{"key":"2279_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/ph18030334","volume":"18","author":"H Wang","year":"2025","unstructured":"Wang H, Xie Y (2025) Advances in ferroptosis research: a comprehensive review of mechanism exploration, drug development, and disease treatment. Pharmaceuticals 18:334. https:\/\/doi.org\/10.3390\/ph18030334","journal-title":"Pharmaceuticals"},{"key":"2279_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin H et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"key":"2279_CR20","doi-asserted-by":"publisher","first-page":"1350011","DOI":"10.3389\/fonc.2024.1350011","volume":"14","author":"S Jiang","year":"2024","unstructured":"Jiang S, Zhang G, Ma Y et al (2024) Ferroptosis in hepatocellular carcinoma, from mechanism to effect. Front Oncol 14:1350011. https:\/\/doi.org\/10.3389\/fonc.2024.1350011","journal-title":"Front Oncol"},{"key":"2279_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s40820-024-01399-0","volume":"16","author":"A Sheikh","year":"2024","unstructured":"Sheikh A, Kesharwani P, Almalki WH et al (2024) Understanding the novel approach of nanoferroptosis for cancer therapy. Nano-Micro Lett 16:188. https:\/\/doi.org\/10.1007\/s40820-024-01399-0","journal-title":"Nano-Micro Lett"},{"key":"2279_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12951-024-02842-5","volume":"22","author":"S Han","year":"2024","unstructured":"Han S, Zou J, Xiao F et al (2024) Nanobiotechnology boosts ferroptosis: opportunities and challenges. J Nanobiotechnol 22:606. https:\/\/doi.org\/10.1186\/s12951-024-02842-5","journal-title":"J Nanobiotechnol"},{"key":"2279_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s12951-024-02909-3","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Xia Q et al (2024) Photothermal Fe3O4 nanoparticles induced Immunogenic ferroptosis for synergistic colorectal cancer therapy. J Nanobiotechnol 22:630. https:\/\/doi.org\/10.1186\/s12951-024-02909-3","journal-title":"J Nanobiotechnol"},{"key":"2279_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates Disulfidptosis. Nat Cell Biol 25:404\u2013414. https:\/\/doi.org\/10.1038\/s41556-023-01091-2","journal-title":"Nat Cell Biol"},{"key":"2279_CR25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","volume":"1861","author":"GO Latunde-Dada","year":"2017","unstructured":"Latunde-Dada GO (2017) Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochimica et biophysica acta (BBA). - Gen Subj 1861:1893\u20131900. https:\/\/doi.org\/10.1016\/j.bbagen.2017.05.019","journal-title":"- Gen Subj"},{"key":"2279_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s40001-025-02623-2","volume":"30","author":"L Song","year":"2025","unstructured":"Song L, Gao F, Man J (2025) Ferroptosis: the potential key roles in idiopathic pulmonary fibrosis. Eur J Med Res 30:341. https:\/\/doi.org\/10.1186\/s40001-025-02623-2","journal-title":"Eur J Med Res"},{"key":"2279_CR27","doi-asserted-by":"publisher","first-page":"e10308","DOI":"10.7554\/eLife.10308","volume":"4","author":"JD Mancias","year":"2015","unstructured":"Mancias JD, Pontano Vaites L, Nissim S et al (2015) Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. eLife 4:e10308. https:\/\/doi.org\/10.7554\/eLife.10308","journal-title":"eLife"},{"key":"2279_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-024-02037-9","volume":"10","author":"S Wang","year":"2024","unstructured":"Wang S, Guo Q, Zhou L, Xia X (2024) Ferroptosis: a double-edged sword. Cell Death Discov 10:265. https:\/\/doi.org\/10.1038\/s41420-024-02037-9","journal-title":"Cell Death Discov"},{"key":"2279_CR29","doi-asserted-by":"publisher","first-page":"637162","DOI":"10.3389\/fcell.2021.637162","volume":"9","author":"X Chen","year":"2021","unstructured":"Chen X, Comish PB, Tang D, Kang R (2021) Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol 9:637162. https:\/\/doi.org\/10.3389\/fcell.2021.637162","journal-title":"Front Cell Dev Biol"},{"key":"2279_CR30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41419-022-04927-1","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Tang L, Zhang Y et al (2022) Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis 13:544. https:\/\/doi.org\/10.1038\/s41419-022-04927-1","journal-title":"Cell Death Dis"},{"key":"2279_CR31","doi-asserted-by":"publisher","first-page":"2527752","DOI":"10.1080\/10717544.2025.2527752","volume":"32","author":"Y Xu","year":"2025","unstructured":"Xu Y, Zhang K, Ye Z et al (2025) Nanomedicine initiates ferroptosis for enhanced lung cancer therapy. Drug Deliv 32:2527752. https:\/\/doi.org\/10.1080\/10717544.2025.2527752","journal-title":"Drug Delivery"},{"key":"2279_CR32","doi-asserted-by":"publisher","first-page":"5779","DOI":"10.2147\/IJN.S523008","volume":"20","author":"L Jing","year":"2025","unstructured":"Jing L, Xiao W, Hu Z et al (2025) A systematic review of nanoparticle-mediated ferroptosis in glioma therapy. IJN 20:5779\u20135797. https:\/\/doi.org\/10.2147\/IJN.S523008","journal-title":"IJN Volume"},{"key":"2279_CR33","doi-asserted-by":"publisher","first-page":"101883","DOI":"10.1016\/j.jddst.2020.101883","volume":"59","author":"B Wang","year":"2020","unstructured":"Wang B, Zhang X, Wang Z, Shi D (2020) Ferroptotic nanomaterials enhance cancer therapy via boosting Fenton-reaction. J Drug Deliv Sci Technol 59:101883. https:\/\/doi.org\/10.1016\/j.jddst.2020.101883","journal-title":"J Drug Deliv Sci Technol"},{"key":"2279_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165\u2013176. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014","journal-title":"Trends Cell Biol"},{"key":"2279_CR35","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3390\/pharmaceutics13111785","volume":"13","author":"N Zaffaroni","year":"2021","unstructured":"Zaffaroni N, Beretta GL (2021) Nanoparticles for ferroptosis therapy in cancer. Pharmaceutics 13:1785. https:\/\/doi.org\/10.3390\/pharmaceutics13111785","journal-title":"Pharmaceutics"},{"key":"2279_CR36","doi-asserted-by":"publisher","first-page":"868630","DOI":"10.3389\/fchem.2022.868630","volume":"10","author":"Z Shi","year":"2022","unstructured":"Shi Z, Zheng J, Tang W et al (2022) Multifunctional nanomaterials for ferroptotic cancer therapy. Front Chem 10:868630. https:\/\/doi.org\/10.3389\/fchem.2022.868630","journal-title":"Front Chem"},{"key":"2279_CR37","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.7150\/thno.65480","volume":"11","author":"L Luo","year":"2021","unstructured":"Luo L, Wang H, Tian W et al (2021) Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 11:9937\u20139952. https:\/\/doi.org\/10.7150\/thno.65480","journal-title":"Theranostics"},{"key":"2279_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","volume":"8","author":"S Sun","year":"2023","unstructured":"Sun S, Shen J, Jiang J et al (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Sig Transduct Target Ther 8:372. https:\/\/doi.org\/10.1038\/s41392-023-01606-1","journal-title":"Sig Transduct Target Ther"},{"key":"2279_CR39","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1039\/C9BM00653B","volume":"7","author":"Y Li","year":"2019","unstructured":"Li Y, Wang X, Yan J et al (2019) Nanoparticle ferritin-bound Erastin and rapamycin: a nanodrug combining autophagy and ferroptosis for anticancer therapy. Biomater Sci 7:3779\u20133787. https:\/\/doi.org\/10.1039\/C9BM00653B","journal-title":"Biomater Sci"},{"key":"2279_CR40","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jconrel.2020.01.048","volume":"320","author":"Q Guan","year":"2020","unstructured":"Guan Q, Guo R, Huang S et al (2020) Mesoporous polydopamine carrying Sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy. J Controlled Release 320:392\u2013403. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.048","journal-title":"J Controlled Release"},{"key":"2279_CR41","doi-asserted-by":"publisher","first-page":"13183","DOI":"10.2147\/IJN.S558103","volume":"20","author":"Y Luo","year":"2025","unstructured":"Luo Y, Lin X, Su C et al (2025) Nanomaterial-Driven regulated cell death: mechanistic insights and novel strategies for tumor therapy. IJN 20:13183\u201313208. https:\/\/doi.org\/10.2147\/IJN.S558103","journal-title":"IJN Volume"},{"key":"2279_CR42","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"key":"2279_CR43","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F (2022) Copper homeostasis and Cuproptosis in health and disease. Sig Transduct Target Ther 7:378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y","journal-title":"Sig Transduct Target Ther"},{"key":"2279_CR44","doi-asserted-by":"publisher","first-page":"917","DOI":"10.14336\/AD.2024.0083","volume":"16","author":"Q Gu","year":"2025","unstructured":"Gu Q, An Y, Xu M et al (2025) Disulfidptosis, a novel cell death pathway: molecular landscape and therapeutic implications. Aging Dis 16:917. https:\/\/doi.org\/10.14336\/AD.2024.0083","journal-title":"Aging Disease"},{"key":"2279_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40364-024-00593-x","volume":"12","author":"J Chen","year":"2024","unstructured":"Chen J, Ma B, Yang Y et al (2024) Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions. Biomark Res 12:45. https:\/\/doi.org\/10.1186\/s40364-024-00593-x","journal-title":"Biomark Res"},{"key":"2279_CR46","doi-asserted-by":"publisher","first-page":"31383","DOI":"10.1038\/s41598-024-82917-3","volume":"14","author":"C Luo","year":"2024","unstructured":"Luo C, Li X, Yan H et al (2024) Iron oxide nanoparticles induce ferroptosis under mild oxidative stress in vitro. Sci Rep 14:31383. https:\/\/doi.org\/10.1038\/s41598-024-82917-3","journal-title":"Sci Rep"},{"key":"2279_CR47","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.3390\/molecules27133970","volume":"27","author":"R Fern\u00e1ndez-Acosta","year":"2022","unstructured":"Fern\u00e1ndez-Acosta R, Iriarte-Mesa C, Alvarez-Alminaque D et al (2022) Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines. Molecules 27:3970. https:\/\/doi.org\/10.3390\/molecules27133970","journal-title":"Molecules"},{"key":"2279_CR48","doi-asserted-by":"publisher","first-page":"nwac167","DOI":"10.1093\/nsr\/nwac167","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, Quan X, Li J et al (2023) Liposomes embedded with pegylated iron oxide nanoparticles enable ferroptosis and combination therapy in cancer. Natl Sci Rev 10:nwac167. https:\/\/doi.org\/10.1093\/nsr\/nwac167","journal-title":"Natl Sci Rev"},{"key":"2279_CR49","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12951-025-03569-7","volume":"23","author":"M Pei","year":"2025","unstructured":"Pei M, Guan X, Hou X et al (2025) A GSH-consuming polymeric nanoparticles drives ferroptosis amplification and combines chemotherapy to amplify breast cancer treatment. J Nanobiotechnol 23:497. https:\/\/doi.org\/10.1186\/s12951-025-03569-7","journal-title":"J Nanobiotechnol"},{"key":"2279_CR50","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1038\/s41467-023-39938-9","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Zhang X-Q, Ho W et al (2023) mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy. Nat Commun 14:4223. https:\/\/doi.org\/10.1038\/s41467-023-39938-9","journal-title":"Nat Commun"},{"key":"2279_CR51","doi-asserted-by":"publisher","first-page":"10354","DOI":"10.1038\/s41598-022-14518-x","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li K, Han X et al (2022) A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis. Sci Rep 12:10354. https:\/\/doi.org\/10.1038\/s41598-022-14518-x","journal-title":"Sci Rep"},{"key":"2279_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12951-017-0276-3","volume":"15","author":"P Sonkusre","year":"2017","unstructured":"Sonkusre P, Cameotra SS (2017) Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. J Nanobiotechnol 15:43. https:\/\/doi.org\/10.1186\/s12951-017-0276-3","journal-title":"J Nanobiotechnol"},{"key":"2279_CR53","doi-asserted-by":"publisher","first-page":"e22106812372775","DOI":"10.2174\/0122106812372775250207074104","volume":"15","author":"C Patil","year":"2025","unstructured":"Patil C, Naik P, Goudanavar TM P (2025) Leveraging magnetic nanoparticles for modern oncology: revolutionary approaches to colorectal cancer treatment and future advancements. NANOASIA 15:e22106812372775. https:\/\/doi.org\/10.2174\/0122106812372775250207074104","journal-title":"NANOASIA"},{"key":"2279_CR54","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22:381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nat Rev Cancer"},{"key":"2279_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/iub.1616","volume":"69","author":"S Doll","year":"2017","unstructured":"Doll S, Conrad M (2017) Iron and ferroptosis: a still ill-defined liaison. IUBMB Life 69:423\u2013434. https:\/\/doi.org\/10.1002\/iub.1616","journal-title":"IUBMB Life"},{"key":"2279_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA (2018) Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci 4:387\u2013396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589","journal-title":"ACS Cent Sci"},{"key":"2279_CR57","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao M, Monian P, Pan Q et al (2016) Ferroptosis is an autophagic cell death process. Cell Res 26:1021\u20131032. https:\/\/doi.org\/10.1038\/cr.2016.95","journal-title":"Cell Res"},{"key":"2279_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cytogfr.2023.08.004","volume":"75","author":"X Zhai","year":"2024","unstructured":"Zhai X, Lin Y, Zhu L et al (2024) Ferroptosis in cancer immunity and immunotherapy: multifaceted interplay and clinical implications. Cytokine Growth Factor Rev 75:101\u2013109. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.08.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"2279_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nanoms.2024.10.013","author":"X Liu","year":"2024","unstructured":"Liu X, He F, Liu M (2024) New opportunities of stimulus-responsive smart nanocarriers in cancer therapy. Nano Mater Sci. https:\/\/doi.org\/10.1016\/j.nanoms.2024.10.013","journal-title":"Nano Mater Sci"},{"key":"2279_CR60","doi-asserted-by":"publisher","first-page":"1704007","DOI":"10.1002\/adma.201704007","volume":"30","author":"Z Shen","year":"2018","unstructured":"Shen Z, Song J, Yung BC et al (2018) Emerging strategies of cancer therapy based on ferroptosis. Adv Mater 30:1704007. https:\/\/doi.org\/10.1002\/adma.201704007","journal-title":"Adv Mater"},{"key":"2279_CR61","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.actbio.2021.05.023","volume":"130","author":"Z Cao","year":"2021","unstructured":"Cao Z, Li D, Wang J, Yang X (2021) Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy. Acta Biomater 130:17\u201331. https:\/\/doi.org\/10.1016\/j.actbio.2021.05.023","journal-title":"Acta Biomater"},{"key":"2279_CR62","doi-asserted-by":"publisher","first-page":"114584","DOI":"10.1016\/j.bcp.2021.114584","volume":"190","author":"G Xu","year":"2021","unstructured":"Xu G, Wang H, Li X et al (2021) Recent progress on targeting ferroptosis for cancer therapy. Biochem Pharmacol 190:114584. https:\/\/doi.org\/10.1016\/j.bcp.2021.114584","journal-title":"Biochem Pharmacol"},{"key":"2279_CR63","doi-asserted-by":"publisher","unstructured":"Zhang Q-W, Baig MMFA, Zhang T-Q et al (2024) Retraction notice to Liposomal valinomycin mediated cellular K\u2009+\u2009leak promoting apoptosis of liver cancer cells [Journal of Controlled Release 337 (2021) 317\u2013328]. J Control Release 371:622. https:\/\/doi.org\/10.1016\/j.jconrel.2022.04.020","DOI":"10.1016\/j.jconrel.2022.04.020"},{"key":"2279_CR64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.actbio.2024.08.036","volume":"187","author":"D Gu","year":"2024","unstructured":"Gu D, Zhu L, Wang Z et al (2024) Multi-responsive cascade enzyme-like catalytic nanoassembly for ferroptosis amplification and nanozyme-assisted mild photothermal therapy. Acta Biomater 187:366\u2013380. https:\/\/doi.org\/10.1016\/j.actbio.2024.08.036","journal-title":"Acta Biomater"},{"key":"2279_CR65","doi-asserted-by":"publisher","first-page":"142650","DOI":"10.1016\/j.ijbiomac.2025.142650","volume":"308","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zheng G, Li X et al (2025) A dual-function hyaluronic acid-encapsulated nanoplatform enables triple GSH depletion for apoptosis-ferroptosis synergistic oncotherapy. Int J Biol Macromol 308:142650. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142650","journal-title":"Int J Biol Macromol"},{"key":"2279_CR66","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.1039\/D1NR01645H","volume":"13","author":"H Cheng","year":"2021","unstructured":"Cheng H, Wang X, Liu X et al (2021) An effective NIR laser\/tumor-microenvironment co-responsive cancer theranostic nanoplatform with multi-modal imaging and therapies. Nanoscale 13:10816\u201310828. https:\/\/doi.org\/10.1039\/D1NR01645H","journal-title":"Nanoscale"},{"key":"2279_CR67","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1111\/jcmm.17529","volume":"26","author":"C Gong","year":"2022","unstructured":"Gong C, Ji Q, Wu M et al (2022) Ferroptosis in tumor immunity and therapy. J Cell Mol Medi 26:5565\u20135579. https:\/\/doi.org\/10.1111\/jcmm.17529","journal-title":"J Cell Mol Medi"},{"key":"2279_CR68","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7150\/thno.67932","volume":"12","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Ma X, Song Y et al (2022) Targeting regulated cell death in tumor nanomedicines. Theranostics 12:817\u2013841. https:\/\/doi.org\/10.7150\/thno.67932","journal-title":"Theranostics"},{"key":"2279_CR69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12951-022-01364-2","volume":"20","author":"N Kaushik","year":"2022","unstructured":"Kaushik N, Borkar SB, Nandanwar SK et al (2022) Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms. J Nanobiotechnol 20:152. https:\/\/doi.org\/10.1186\/s12951-022-01364-2","journal-title":"J Nanobiotechnol"},{"key":"2279_CR70","doi-asserted-by":"publisher","first-page":"735965","DOI":"10.3389\/fphar.2021.735965","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu T, Li X et al (2021) Ferroptosis-Inducing nanomedicine for cancer therapy. Front Pharmacol 12:735965. https:\/\/doi.org\/10.3389\/fphar.2021.735965","journal-title":"Front Pharmacol"},{"key":"2279_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12951-024-02297-8","volume":"22","author":"W Deng","year":"2024","unstructured":"Deng W, Shang H, Tong Y et al (2024) The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnol 22:97. https:\/\/doi.org\/10.1186\/s12951-024-02297-8","journal-title":"J Nanobiotechnol"},{"key":"2279_CR72","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1039\/D3QM01202F","volume":"8","author":"Y Ming","year":"2024","unstructured":"Ming Y, Huang M, Huang Y et al (2024) Nanozyme-enhanced ferroptosis for cancer treatment. Mater Chem Front 8:1685\u20131702. https:\/\/doi.org\/10.1039\/D3QM01202F","journal-title":"Mater Chem Front"},{"key":"2279_CR73","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.apsb.2024.10.006","volume":"15","author":"D Liu","year":"2025","unstructured":"Liu D, Wang Y, Sun Q et al (2025) Iron and SiRNA co-encapsulated ferritin nanocages induce ferroptosis synergistically for cancer therapy. Acta Pharm Sinica B 15:526\u2013541. https:\/\/doi.org\/10.1016\/j.apsb.2024.10.006","journal-title":"Acta Pharm Sinica B"},{"key":"2279_CR74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-024-02088-7","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang H, Fleishman JS, Cheng S et al (2024) Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance. Mol Cancer 23:177. https:\/\/doi.org\/10.1186\/s12943-024-02088-7","journal-title":"Mol Cancer"},{"key":"2279_CR75","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.7150\/thno.46903","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee J, You JH, Shin D, Roh J-L (2020) Inhibition of glutaredoxin 5 predisposes Cisplatin-resistant head and neck cancer cells to ferroptosis. Theranostics 10:7775\u20137786. https:\/\/doi.org\/10.7150\/thno.46903","journal-title":"Theranostics"},{"key":"2279_CR76","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12951-024-02883-w","volume":"22","author":"M Li","year":"2024","unstructured":"Li M, Li Y, Zheng J et al (2024) Ultrasound-responsive nanocarriers with SiRNA and Fe3O4 regulate macrophage polarization and phagocytosis for augmented non-small cell lung cancer immunotherapy. J Nanobiotechnol 22:605. https:\/\/doi.org\/10.1186\/s12951-024-02883-w","journal-title":"J Nanobiotechnol"},{"key":"2279_CR77","doi-asserted-by":"publisher","first-page":"104818","DOI":"10.1016\/j.critrevonc.2025.104818","volume":"212","author":"J Hu","year":"2025","unstructured":"Hu J, Cui L, Hou B et al (2025) Ferroptosis in tumor associated immune cells: a double-edged sword against tumors. Crit Rev Oncol\/Hematol 212:104818. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104818","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2279_CR78","doi-asserted-by":"publisher","first-page":"1591172","DOI":"10.3389\/fimmu.2025.1591172","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhan J, Wang J et al (2025) Ferroptosis: a double-edged sword that enhances radiation sensitivity and facilitates radiation-induced injury in tumors. Front Immunol 16:1591172. https:\/\/doi.org\/10.3389\/fimmu.2025.1591172","journal-title":"Front Immunol"},{"key":"2279_CR79","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41388-024-03050-z","volume":"43","author":"J Song","year":"2024","unstructured":"Song J, Zhang J, Shi Y et al (2024) Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis. Oncogene 43:2000\u20132014. https:\/\/doi.org\/10.1038\/s41388-024-03050-z","journal-title":"Oncogene"},{"key":"2279_CR80","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10555-019-09787-4","volume":"38","author":"A Ibrahim-Hashim","year":"2019","unstructured":"Ibrahim-Hashim A, Estrella V (2019) Acidosis and cancer: from mechanism to neutralization. Cancer Metastasis Rev 38:149\u2013155. https:\/\/doi.org\/10.1007\/s10555-019-09787-4","journal-title":"Cancer Metastasis Rev"},{"key":"2279_CR81","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1158\/0008-5472.CAN-19-0487","volume":"79","author":"B Gan","year":"2019","unstructured":"Gan B (2019) DUBbing ferroptosis in cancer cells. Cancer Res 79:1749\u20131750. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0487","journal-title":"Cancer Res"},{"key":"2279_CR82","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.ajps.2023.100829","volume":"18","author":"H Wang","year":"2023","unstructured":"Wang H, Qiao C, Guan Q et al (2023) Nanoparticle-mediated synergistic anticancer effect of ferroptosis and photodynamic therapy: novel insights and perspectives. Asian J Pharm Sci 18:100829. https:\/\/doi.org\/10.1016\/j.ajps.2023.100829","journal-title":"Asian J Pharm Sci"},{"key":"2279_CR83","doi-asserted-by":"publisher","first-page":"1650219","DOI":"10.3389\/fonc.2025.1650219","volume":"15","author":"W Gao","year":"2025","unstructured":"Gao W, Tan J, Yu C (2025) Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives. Front Oncol 15:1650219. https:\/\/doi.org\/10.3389\/fonc.2025.1650219","journal-title":"Front Oncol"},{"key":"2279_CR84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B (2024) The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42:513\u2013534. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011","journal-title":"Cancer Cell"},{"key":"2279_CR85","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.4110\/in.2025.25.e6","volume":"25","author":"N Jang","year":"2025","unstructured":"Jang N, Kim I-K, Jung D et al (2025) Regulation of ferroptosis in cancer and immune cells. Immune Netw 25:e6. https:\/\/doi.org\/10.4110\/in.2025.25.e6","journal-title":"Immune Netw"},{"key":"2279_CR86","doi-asserted-by":"publisher","first-page":"176124","DOI":"10.1016\/j.ejphar.2023.176124","volume":"961","author":"W Zhu","year":"2023","unstructured":"Zhu W, Liu X, Yang L et al (2023) Ferroptosis and tumor immunity: in perspective of the major cell components in the tumor microenvironment. Eur J Pharmacol 961:176124. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176124","journal-title":"Eur J Pharmacol"},{"key":"2279_CR87","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, Demuynck R, Naessens F et al (2024) Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer 10:407\u2013416. https:\/\/doi.org\/10.1016\/j.trecan.2024.01.013","journal-title":"Trends Cancer"},{"key":"2279_CR88","doi-asserted-by":"publisher","first-page":"1862949","DOI":"10.1080\/2162402X.2020.1862949","volume":"10","author":"D Tang","year":"2021","unstructured":"Tang D, Kepp O, Kroemer G (2021) Ferroptosis becomes immunogenic: implications for anticancer treatments. OncoImmunology 10:1862949. https:\/\/doi.org\/10.1080\/2162402X.2020.1862949","journal-title":"OncoImmunology"},{"key":"2279_CR89","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41420-024-01958-9","volume":"10","author":"C Chen","year":"2024","unstructured":"Chen C, Liu J, Lin X et al (2024) Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis. Cell Death Discov 10:189. https:\/\/doi.org\/10.1038\/s41420-024-01958-9","journal-title":"Cell Death Discov"},{"key":"2279_CR90","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18:280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nat Rev Clin Oncol"},{"key":"2279_CR91","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van Der Meeren L et al (2020) Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer 8:e001369. https:\/\/doi.org\/10.1136\/jitc-2020-001369","journal-title":"J Immunother Cancer"},{"key":"2279_CR92","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41420-025-02495-9","volume":"11","author":"S Wan","year":"2025","unstructured":"Wan S, Liang C, Wu C et al (2025) Disulfidptosis in tumor progression. Cell Death Discov 11:205. https:\/\/doi.org\/10.1038\/s41420-025-02495-9","journal-title":"Cell Death Discov"},{"key":"2279_CR93","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.2147\/IJN.S464178","volume":"19","author":"H Xiang","year":"2024","unstructured":"Xiang H, Shen B, Zhang C, Li R (2024) Bioactive nanoliposomes for enhanced sonodynamic-triggered disulfidptosis-like cancer cell death via lipid peroxidation. IJN 19:8929\u20138947. https:\/\/doi.org\/10.2147\/IJN.S464178","journal-title":"IJN Volume"},{"key":"2279_CR94","doi-asserted-by":"publisher","first-page":"2309388","DOI":"10.1002\/advs.202309388","volume":"11","author":"F Hu","year":"2024","unstructured":"Hu F, Huang J, Bing T et al (2024) Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy. Adv Sci 11:2309388. https:\/\/doi.org\/10.1002\/advs.202309388","journal-title":"Adv Sci"},{"key":"2279_CR95","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.3390\/cancers15215209","volume":"15","author":"X Cheng","year":"2023","unstructured":"Cheng X, Zhao F, Ke B et al (2023) Harnessing ferroptosis to overcome drug resistance in colorectal cancer: promising therapeutic approaches. Cancers 15:5209. https:\/\/doi.org\/10.3390\/cancers15215209","journal-title":"Cancers"},{"key":"2279_CR96","doi-asserted-by":"publisher","first-page":"879317","DOI":"10.3389\/fphar.2022.879317","volume":"13","author":"Z Nie","year":"2022","unstructured":"Nie Z, Chen M, Gao Y et al (2022) Ferroptosis and tumor drug resistance: current status and major challenges. Front Pharmacol 13:879317. https:\/\/doi.org\/10.3389\/fphar.2022.879317","journal-title":"Front Pharmacol"},{"key":"2279_CR97","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49\u201363. https:\/\/doi.org\/10.1038\/nrm3722","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2279_CR98","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/jcb.30173","volume":"123","author":"M Kulbay","year":"2022","unstructured":"Kulbay M, Paimboeuf A, Ozdemir D, Bernier J (2022) Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies. J Cell Biochem 123:1736\u20131761. https:\/\/doi.org\/10.1002\/jcb.30173","journal-title":"J Cell Biochem"},{"key":"2279_CR99","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F et al (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333\u2013339. https:\/\/doi.org\/10.1038\/nature12634","journal-title":"Nature"},{"key":"2279_CR100","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s10495-007-0087-3","volume":"12","author":"AM Hunter","year":"2007","unstructured":"Hunter AM, LaCasse EC, Korneluk RG (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12:1543\u20131568. https:\/\/doi.org\/10.1007\/s10495-007-0087-3","journal-title":"Apoptosis"},{"key":"2279_CR101","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.3390\/cancers13174363","volume":"13","author":"CM Neophytou","year":"2021","unstructured":"Neophytou CM, Trougakos IP, Erin N, Papageorgis P (2021) Apoptosis deregulation and the development of cancer multi-drug resistance. Cancers 13:4363. https:\/\/doi.org\/10.3390\/cancers13174363","journal-title":"Cancers"},{"key":"2279_CR102","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"2279_CR103","doi-asserted-by":"publisher","first-page":"1108836","DOI":"10.3389\/fphar.2022.1108836","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Jiang G, He P et al (2023) Mechanism of ferroptosis in traditional Chinese medicine for clinical treatment: a review. Front Pharmacol 13:1108836. https:\/\/doi.org\/10.3389\/fphar.2022.1108836","journal-title":"Front Pharmacol"},{"key":"2279_CR104","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature 551:247\u2013250. https:\/\/doi.org\/10.1038\/nature24297","journal-title":"Nature"},{"key":"2279_CR105","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD et al (2017) Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547:453\u2013457. https:\/\/doi.org\/10.1038\/nature23007","journal-title":"Nature"},{"key":"2279_CR106","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M et al (2014) Pharmacological Inhibition of cystine\u2013glutamate exchange induces Endoplasmic reticulum stress and ferroptosis. eLife 3:e02523. https:\/\/doi.org\/10.7554\/eLife.02523","journal-title":"eLife"},{"key":"2279_CR107","doi-asserted-by":"publisher","first-page":"115933","DOI":"10.1016\/j.bcp.2023.115933","volume":"219","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li X, Xia R, Zhang H-S (2024) Ferroptosis resistance in cancer: recent advances and future perspectives. Biochem Pharmacol 219:115933. https:\/\/doi.org\/10.1016\/j.bcp.2023.115933","journal-title":"Biochem Pharmacol"},{"key":"2279_CR108","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.127","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu G, Chen X (2024) Mechanism of ferroptosis resistance in cancer cells. Cancer Drug Resist. https:\/\/doi.org\/10.20517\/cdr.2024.127","journal-title":"Cancer Drug Resist"},{"key":"2279_CR109","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M (2019) Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer 19:405\u2013414. https:\/\/doi.org\/10.1038\/s41568-019-0149-1","journal-title":"Nat Rev Cancer"},{"key":"2279_CR110","doi-asserted-by":"publisher","first-page":"137040","DOI":"10.1016\/j.cej.2022.137040","volume":"446","author":"H Ge","year":"2022","unstructured":"Ge H, Du J, Zheng J et al (2022) Effective treatment of cisplatin-resistant ovarian tumors with a MoS2-based sonosensitizer and nanoenzyme capable of reversing the resistant-microenvironment and enhancing ferroptosis and apoptosis. Chem Eng J 446:137040. https:\/\/doi.org\/10.1016\/j.cej.2022.137040","journal-title":"Chem Eng J"},{"key":"2279_CR111","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12951-023-01963-7","volume":"21","author":"P He","year":"2023","unstructured":"He P, Xu S, Miao Z et al (2023) Anti-Her2 affibody-decorated Arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance. J Nanobiotechnol 21:203. https:\/\/doi.org\/10.1186\/s12951-023-01963-7","journal-title":"J Nanobiotechnol"},{"key":"2279_CR112","doi-asserted-by":"publisher","first-page":"100457","DOI":"10.1016\/j.mtbio.2022.100457","volume":"17","author":"C Bae","year":"2022","unstructured":"Bae C, Kim H, Kook Y-M et al (2022) Induction of ferroptosis using functionalized iron-based nanoparticles for anti-cancer therapy. Mater Today Bio 17:100457. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100457","journal-title":"Mater Today Bio"},{"key":"2279_CR113","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.3390\/cancers15205043","volume":"15","author":"Y Huang","year":"2023","unstructured":"Huang Y, Li X, Zhang Z et al (2023) Photodynamic therapy combined with ferroptosis is a synergistic antitumor therapy strategy. Cancers 15:5043. https:\/\/doi.org\/10.3390\/cancers15205043","journal-title":"Cancers"},{"key":"2279_CR114","doi-asserted-by":"publisher","first-page":"155048","DOI":"10.1016\/j.cej.2024.155048","volume":"498","author":"Z Wu","year":"2024","unstructured":"Wu Z, Chen K, Mo W et al (2024) Multimodal enhancement of ferroptosis for synergistic cascade colorectal cancer therapy. Chem Eng J 498:155048. https:\/\/doi.org\/10.1016\/j.cej.2024.155048","journal-title":"Chem Eng J"},{"key":"2279_CR115","doi-asserted-by":"publisher","first-page":"e13644","DOI":"10.1111\/cpr.13644","volume":"57","author":"L Yu","year":"2024","unstructured":"Yu L, Huang K, Liao Y et al (2024) Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD \u20101\/ PD\u2010L1 cancer immunotherapy. Cell Prolif 57:e13644. https:\/\/doi.org\/10.1111\/cpr.13644","journal-title":"Cell Prolif"},{"key":"2279_CR116","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","volume":"20","author":"T Luo","year":"2022","unstructured":"Luo T, Wang Y, Wang J (2022) Ferroptosis assassinates tumor. J Nanobiotechnol 20:467. https:\/\/doi.org\/10.1186\/s12951-022-01663-8","journal-title":"J Nanobiotechnol"},{"key":"2279_CR117","doi-asserted-by":"publisher","first-page":"1466180","DOI":"10.3389\/fimmu.2024.1466180","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Li G, Zhang J et al (2024) A novel Hollow iron nanoparticle system loading PEG-Fe3O4 with C5a receptor antagonist for breast cancer treatment. Front Immunol 15:1466180. https:\/\/doi.org\/10.3389\/fimmu.2024.1466180","journal-title":"Front Immunol"},{"key":"2279_CR118","doi-asserted-by":"publisher","first-page":"670224","DOI":"10.3389\/fphar.2021.670224","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Yang J, Chen C et al (2021) Polyphyllin \u2162-Induced ferroptosis in MDA-MB-231 Triple-Negative breast cancer cells can be protected against by KLF4-Mediated upregulation of xCT. Front Pharmacol 12:670224. https:\/\/doi.org\/10.3389\/fphar.2021.670224","journal-title":"Front Pharmacol"},{"key":"2279_CR119","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.mtbio.2025.101848","volume":"32","author":"Y Yan","year":"2025","unstructured":"Yan Y, Hu J, Han N et al (2025) Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects through synergistically potentiating ferroptosis and remodeling tumor immune microenvironment. Mater Today Bio 32:101848. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101848","journal-title":"Mater Today Bio"},{"key":"2279_CR120","doi-asserted-by":"publisher","first-page":"15328","DOI":"10.1021\/acsnano.3c04632","volume":"17","author":"H Yang","year":"2023","unstructured":"Yang H, Yao X, Liu Y et al (2023) Ferroptosis nanomedicine: clinical challenges and opportunities for modulating tumor metabolic and immunological landscape. ACS Nano 17:15328\u201315353. https:\/\/doi.org\/10.1021\/acsnano.3c04632","journal-title":"ACS Nano"},{"key":"2279_CR121","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","volume":"6","author":"JM Ubellacker","year":"2025","unstructured":"Ubellacker JM, Dixon SJ (2025) Prospects for ferroptosis therapies in cancer. Nat Cancer 6:1326\u20131336. https:\/\/doi.org\/10.1038\/s43018-025-01037-7","journal-title":"Nat Cancer"},{"key":"2279_CR122","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking Metabolism, redox Biology, and disease. Cell 171:273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"2279_CR123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s40820-023-01018-4","volume":"15","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Kuang G, Li W et al (2023) Stimuli-Responsive gene delivery nanocarriers for cancer therapy. Nano-Micro Lett 15:44. https:\/\/doi.org\/10.1007\/s40820-023-01018-4","journal-title":"Nano-Micro Lett"},{"key":"2279_CR124","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1039\/D1NH00506E","volume":"7","author":"M Zhang","year":"2022","unstructured":"Zhang M, Qin X, Zhao Z et al (2022) A self-amplifying nanodrug to manipulate the Janus-faced nature of ferroptosis for tumor therapy. Nanoscale Horiz 7:198\u2013210. https:\/\/doi.org\/10.1039\/D1NH00506E","journal-title":"Nanoscale Horiz"},{"key":"2279_CR125","doi-asserted-by":"publisher","first-page":"103858","DOI":"10.1016\/j.redox.2025.103858","volume":"86","author":"Y Matsuoka","year":"2025","unstructured":"Matsuoka Y, Katsumata Y, Chu P et al (2025) Monitoring ferroptosis in vivo: iron-driven volatile oxidized lipids as breath biomarkers. Redox Biol 86:103858. https:\/\/doi.org\/10.1016\/j.redox.2025.103858","journal-title":"Redox Biol"},{"key":"2279_CR126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-031-39171-2_6","volume-title":"Ferroptosis in health and disease","author":"B Kolbrink","year":"2023","unstructured":"Kolbrink B, Von Samson-Himmelstjerna FA, Riebeling T et al (2023) The ongoing search for a biomarker of ferroptosis. In: Tang D (ed) Ferroptosis in health and disease. Springer, Cham, pp 121\u2013135"},{"key":"2279_CR127","doi-asserted-by":"publisher","first-page":"101584","DOI":"10.1016\/j.ijcha.2024.101584","volume":"56","author":"H Liu","year":"2025","unstructured":"Liu H, Xu Y, Liu Y et al (2025) Identification of novel ferroptosis-related biomarkers associated with the oxidative stress pathways in ischemic cardiomyopathy. IJC Heart Vasc 56:101584. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101584","journal-title":"IJC Heart Vasculature"},{"key":"2279_CR128","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10565-025-10067-x","volume":"41","author":"J Gao","year":"2025","unstructured":"Gao J, Ma N, Ni S, Han X (2025) Intersection of ferroptosis and nanomaterials brings benefits to breast cancer. Cell Biol Toxicol 41:119. https:\/\/doi.org\/10.1007\/s10565-025-10067-x","journal-title":"Cell Biol Toxicol"},{"key":"2279_CR129","doi-asserted-by":"publisher","first-page":"1499125","DOI":"10.3389\/fonc.2024.1499125","volume":"14","author":"C Peng","year":"2024","unstructured":"Peng C, Chen Y, Jiang M (2024) Targeting ferroptosis: a promising strategy to overcome drug resistance in breast cancer. Front Oncol 14:1499125. https:\/\/doi.org\/10.3389\/fonc.2024.1499125","journal-title":"Front Oncol"},{"key":"2279_CR130","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.ctarc.2025.100913","volume":"43","author":"OA Ojo","year":"2025","unstructured":"Ojo OA, Grant S, Nwafor-Ezeh PI et al (2025) Ferroptosis as the new approach to cancer therapy. Cancer Treat Res Commun 43:100913. https:\/\/doi.org\/10.1016\/j.ctarc.2025.100913","journal-title":"Cancer Treat Res Commun"},{"key":"2279_CR131","doi-asserted-by":"publisher","first-page":"1275154","DOI":"10.3389\/fgene.2023.1275154","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B, Zhao L, Yang R, Xu T (2023) The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. Front Genet 14:1275154. https:\/\/doi.org\/10.3389\/fgene.2023.1275154","journal-title":"Front Genet"},{"key":"2279_CR132","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.ajps.2024.100939","volume":"19","author":"X Wang","year":"2024","unstructured":"Wang X, Ren X, Lin X et al (2024) Recent progress of ferroptosis in cancers and drug discovery. Asian J Pharm Sci 19:100939. https:\/\/doi.org\/10.1016\/j.ajps.2024.100939","journal-title":"Asian J Pharm Sci"},{"key":"2279_CR133","doi-asserted-by":"publisher","first-page":"114918","DOI":"10.1016\/j.colsurfb.2025.114918","volume":"255","author":"H Zheng","year":"2025","unstructured":"Zheng H, Mao X, Chen Z et al (2025) ATB0,+-targeted nanoparticles trigger STAT3-ferroptosis regulatory axis for enhanced gastric cancer therapy. Colloids Surf B 255:114918. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114918","journal-title":"Colloids Surf B"},{"key":"2279_CR134","doi-asserted-by":"publisher","first-page":"1629620","DOI":"10.3389\/fimmu.2025.1629620","volume":"16","author":"Z Shan","year":"2025","unstructured":"Shan Z, Liu F (2025) Targeting ferroptosis, pyroptosis and necroptosis for cancer immunotherapy in melanoma: mechanistic insights and clinical perspectives. Front Immunol 16:1629620. https:\/\/doi.org\/10.3389\/fimmu.2025.1629620","journal-title":"Front Immunol"},{"key":"2279_CR135","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/cells12020311","volume":"12","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, You B, Ji C et al (2023) Implications of crosstalk between Exosome-Mediated ferroptosis and diseases for pathogenesis and treatment. Cells 12:311. https:\/\/doi.org\/10.3390\/cells12020311","journal-title":"Cells"},{"key":"2279_CR136","doi-asserted-by":"publisher","first-page":"765859","DOI":"10.3389\/fcell.2021.765859","volume":"9","author":"Z Tang","year":"2021","unstructured":"Tang Z, Huang Z, Huang Y et al (2021) Ferroptosis: the silver lining of cancer therapy. Front Cell Dev Biol 9:765859. https:\/\/doi.org\/10.3389\/fcell.2021.765859","journal-title":"Front Cell Dev Biol"},{"key":"2279_CR137","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3892\/br.2024.1839","volume":"21","author":"X Wang","year":"2024","unstructured":"Wang X, Li K, Song T et al (2024) Advances in ferroptosis in head and neck cancer (Review). Biomed Rep 21:151. https:\/\/doi.org\/10.3892\/br.2024.1839","journal-title":"Biomed Rep"},{"key":"2279_CR138","doi-asserted-by":"publisher","first-page":"1226044","DOI":"10.3389\/fcell.2023.1226044","volume":"11","author":"HT Endale","year":"2023","unstructured":"Endale HT, Tesfaye W, Mengstie TA (2023) ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol 11:1226044. https:\/\/doi.org\/10.3389\/fcell.2023.1226044","journal-title":"Front Cell Dev Biol"},{"key":"2279_CR139","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3892\/mmr.2023.13085","volume":"28","author":"Q Nie","year":"2023","unstructured":"Nie Q, Chen W, Zhang T et al (2023) Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with Paclitaxel. Mol Med Rep 28:198. https:\/\/doi.org\/10.3892\/mmr.2023.13085","journal-title":"Mol Med Rep"},{"key":"2279_CR140","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/17425247.2024.2379937","volume":"21","author":"H Zhou","year":"2024","unstructured":"Zhou H, Cheng Y, Huang Q, Xiao J (2024) Regulation of ferroptosis by nanotechnology for enhanced cancer immunotherapy. Expert Opin Drug Deliv 21:921\u2013943. https:\/\/doi.org\/10.1080\/17425247.2024.2379937","journal-title":"Expert Opin Drug Deliv"},{"key":"2279_CR141","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jsps.2023.02.008","volume":"31","author":"D Yan","year":"2023","unstructured":"Yan D, Wu Z, Qi X (2023) Ferroptosis-related metabolic mechanism and nanoparticulate anticancer drug delivery systems based on ferroptosis. Saudi Pharm J 31:554\u2013568. https:\/\/doi.org\/10.1016\/j.jsps.2023.02.008","journal-title":"Saudi Pharm J"},{"key":"2279_CR142","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Berleth N, Wu W et al (2021) Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR Inhibition to kill bladder cancer cells. Cell Death Dis 12:1028. https:\/\/doi.org\/10.1038\/s41419-021-04306-2","journal-title":"Cell Death Dis"},{"key":"2279_CR143","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-024-02198-2","volume":"24","author":"MA Freitas-Cortez","year":"2025","unstructured":"Freitas-Cortez MA, Masrorpour F, Jiang H et al (2025) Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Mol Cancer 24:40. https:\/\/doi.org\/10.1186\/s12943-024-02198-2","journal-title":"Mol Cancer"},{"key":"2279_CR144","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noac033","volume":"24","author":"T Liu","year":"2022","unstructured":"Liu T, Zhu C, Chen X et al (2022) Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance. Neurooncology 24:1113\u20131125. https:\/\/doi.org\/10.1093\/neuonc\/noac033","journal-title":"Neurooncology"},{"key":"2279_CR145","doi-asserted-by":"publisher","first-page":"rbad004","DOI":"10.1093\/rb\/rbad004","volume":"10","author":"Q Liu","year":"2023","unstructured":"Liu Q, Zhao Y, Zhou H, Chen C (2023) Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regen Biomater 10:rbad004. https:\/\/doi.org\/10.1093\/rb\/rbad004","journal-title":"Regenerative Biomaterials"},{"key":"2279_CR146","doi-asserted-by":"publisher","first-page":"1416382","DOI":"10.3389\/fphar.2024.1416382","volume":"15","author":"KP Adzavon","year":"2024","unstructured":"Adzavon KP, Zhao W, He X, Sheng W (2024) Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution. Front Pharmacol 15:1416382. https:\/\/doi.org\/10.3389\/fphar.2024.1416382","journal-title":"Front Pharmacol"},{"key":"2279_CR147","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jconrel.2022.01.034","volume":"344","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun T, Jiang C (2022) Nanodrug delivery systems for ferroptosis-based cancer therapy. J Controll Release 344:289\u2013301. https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.034","journal-title":"J Controlled Release"},{"key":"2279_CR148","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41467-023-44665-2","volume":"15","author":"D-Y Hou","year":"2024","unstructured":"Hou D-Y, Cheng D-B, Zhang N-Y et al (2024) In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy. Nat Commun 15:454. https:\/\/doi.org\/10.1038\/s41467-023-44665-2","journal-title":"Nat Commun"},{"key":"2279_CR149","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-023-05930-w","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Wang W, Abdul Razak SR et al (2023) Ferroptosis as a potential target for cancer therapy. Cell Death Dis 14:460. https:\/\/doi.org\/10.1038\/s41419-023-05930-w","journal-title":"Cell Death Dis"},{"key":"2279_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.celbio.2025.100222","volume-title":"Nanotechnology for tumor ferroptosis","author":"Z Wang","year":"2025","unstructured":"Wang Z, Xu H, Li M et al (2025) Nanotechnology for tumor ferroptosis. Cell Biomater https:\/\/doi.org\/10.1016\/j.celbio.2025.100222"},{"key":"2279_CR151","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/acsmaterialslett.3c01265","volume":"6","author":"Z Xu","year":"2024","unstructured":"Xu Z, Zhang L, Gong M et al (2024) Fe-Mediated Self-Assembled nanodrug for tumor microenvironment activated synergistic Ferroptosis-Based-Chemodynamic\/Chemo therapy and magnetic resonance imaging. ACS Mater Lett 6:656\u2013665. https:\/\/doi.org\/10.1021\/acsmaterialslett.3c01265","journal-title":"ACS Mater Lett"},{"key":"2279_CR152","doi-asserted-by":"publisher","first-page":"2310309","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Chen Y et al (2024) Nanoparticles synergize ferroptosis and Cuproptosis to potentiate cancer immunotherapy. Adv Sci 11:2310309. https:\/\/doi.org\/10.1002\/advs.202310309","journal-title":"Adv Sci"},{"key":"2279_CR153","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12915-025-02154-6","volume":"23","author":"R Fern\u00e1ndez-Acosta","year":"2025","unstructured":"Fern\u00e1ndez-Acosta R, Vintea I, Koeken I et al (2025) Harnessing ferroptosis for precision oncology: challenges and prospects. BMC Biol 23:57. https:\/\/doi.org\/10.1186\/s12915-025-02154-6","journal-title":"BMC Biol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02279-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:04:51Z","timestamp":1774076691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":153,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02279-1","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"62"}}